Albemarle is a “survivorship alpha” lithium leader: after the 2023–2024 price crash cleansed high-cost supply, ALB’s cost-curve advantage, capital discipline, and deleveraging set up powerful operating leverage into the next deficit cycle.
Overview
Albemarle (ALB) is presented as a “survivorship alpha” lithium leader emerging from the 2023–2024 downturn in far stronger strategic shape. After an ~80% collapse in spot lithium prices forced supply rationalization (high-cost producers curtailed or exited), Albemarle enters 2026 as a leaner operator due to a major pivot from aggressive growth to capital discipline and efficiency. The thesis rests on (1) a likely re-emergent lithium supply deficit by 2026–2027 driven by underinvestment, (2) ALB’s first-quartile cost position anchored by Greenbushes (hard rock) and Atacama (brine), and (3) a deleveraging path that preserves liquidity without equity dilution (capex cuts and the Ketjen stake sale). Financials show a trough in FY2024 (net loss ~$1.2B on $5.4B sales) followed by stabilization in 2025 as cost actions took hold (Q3 2025 operating cash flow +57% YoY; adjusted EBITDA $226M despite GAAP loss). Valuation at ~$145.88/share and ~8.5x 2026E EV/EBITDA is argued to underprice the operating leverage as lithium normalizes toward marginal cost ($15k–$20k/t LCE). Technicals reinforce a trend reversal with price above the 200-day MA and a golden cross.